First-Line Systemic Chemotherapy with Folfoxiri Followed by Radical Surgical Resection of Metastases for the Treatment of Unresectable Metastatic Colorectal Cancer ... View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2009

AUTHORS

Enrico Vasile , Gianluca Masi , Fotios Loupakis , Samanta Cupini , Giacomo Giulio Baldi , Lorenzo Fornaro , Irene Stasi , Lisa Salvatore , Alfredo Falcone

ABSTRACT

Prognosis of patients with initially unresectable metastatic colorectal cancer (MCRC) can be improved if chemotherapy induces a significant down-sizing of metastatic disease thus allowing a radical (R0) surgical resection of metastases (mts). Moreover, it has been demonstrated that there is a clear correlation between the activity of the regimen used and the rate of secondary R0 resections. We studied the triple drug combination FOLFOXIRI (irinotecan 165 mg/m2 on day 1, oxaliplatin 85 mg/m2 on day 1, 1-leucovorin 200 mg/m2 on day 1, 5-fluorouracil 3,200 mg/m2 48-h flat continuous infusion starting on day 1, repeated every 2 weeks) in phase II and III trials. Overall 196 patients with initially unresectable MCRC not selected for a neoadjuvant strategy were treated. This regimen was associated with a good activity (response rate ranging from 60 to 72%) and 37 patients (19%) underwent to a secondary R0 surgery on metastases after chemotherapy. Characteristics of the 37 radically resected patients were: median age 64 years (45-73), ECOG PS ≥ 1 in 11 patients (30%), median CEA 10 ng/ml (1–288), liver involvement ≥25% in 18 patients (49%). Sites of disease were: liver only 25 patients (68%), lung only 4 patients (11%), liver + lymphnodes 5 patients (13%), liver + peritoneum 1 patient (3%), liver + lung 2 patients (5%). Mts were synchronous in 24 patients (65%) and metachronous in 13 patients (35%). There was no perioperative mortality. After a median follow up of 61 months, median OS is 40.8 months. The actuarial 5-year survival from the onset of chemotherapy is 45%. In 11 patients who showed progression of disease after surgery, a surgical re-resection and/or radiofrequency ablation was performed. These data indicate that FOLFOXIRI allows an R0 surgical resection in about 1 out of 5 patients with initially unresectable MCRC not selected for a neoadjuvant approach. Long term survival of resected patients is significant and comparable with the survival of patients resectable up-front. This FOLFOXIRI regimen should be considered as neoadjuvant treatment in initially unresectable metastatic colorectal cancer patients. More... »

PAGES

285-293

Book

TITLE

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy

ISBN

978-1-60327-458-6
978-1-60327-459-3

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-60327-459-3_32

DOI

http://dx.doi.org/10.1007/978-1-60327-459-3_32

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048001080


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy", 
            "Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vasile", 
        "givenName": "Enrico", 
        "id": "sg:person.01006607213.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006607213.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masi", 
        "givenName": "Gianluca", 
        "id": "sg:person.01062670207.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062670207.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loupakis", 
        "givenName": "Fotios", 
        "id": "sg:person.01175106504.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175106504.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cupini", 
        "givenName": "Samanta", 
        "id": "sg:person.0602037071.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602037071.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baldi", 
        "givenName": "Giacomo Giulio", 
        "id": "sg:person.0712424371.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712424371.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fornaro", 
        "givenName": "Lorenzo", 
        "id": "sg:person.01164506727.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164506727.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stasi", 
        "givenName": "Irene", 
        "id": "sg:person.01276011262.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276011262.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salvatore", 
        "givenName": "Lisa", 
        "id": "sg:person.01157052153.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157052153.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy", 
            "Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Falcone", 
        "givenName": "Alfredo", 
        "id": "sg:person.01006230145.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006230145.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6603988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000295738", 
          "https://doi.org/10.1038/sj.bjc.6603988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.05.546", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001923432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)02034-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006410174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200009283431302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010303757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001040051278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014305349", 
          "https://doi.org/10.1007/s001040051278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10434-001-0347-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015538540", 
          "https://doi.org/10.1007/s10434-001-0347-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdh470", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017702605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdh217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024390903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.05.113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025767346"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi246", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028947330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.0928", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029306962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2006.04.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029538220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.11.037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034270716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.12-7-825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037813481"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00316981", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038122014", 
          "https://doi.org/10.1007/bf00316981"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00316981", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038122014", 
          "https://doi.org/10.1007/bf00316981"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01655817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038580705", 
          "https://doi.org/10.1007/bf01655817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01655817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038580705", 
          "https://doi.org/10.1007/bf01655817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042776899", 
          "https://doi.org/10.1038/sj.bjc.6603233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042776899", 
          "https://doi.org/10.1038/sj.bjc.6603233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.1999.1254", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044768203", 
          "https://doi.org/10.1054/bjoc.1999.1254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2004.03.085", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046932661", 
          "https://doi.org/10.1245/aso.2004.03.085"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2004.03.085", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046932661", 
          "https://doi.org/10.1245/aso.2004.03.085"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.1800840719", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049625308"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(94)92529-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051430862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(94)92529-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051430862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdg731", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051607149"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jamcollsurg.2005.11.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051692921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/ca.2007.0010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052065817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008347829017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303343"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-199610000-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060134371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.12.075", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203208"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.00.349", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.1.136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074572224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.16.2938", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074684744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079658535", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.3.938", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083057206"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009", 
    "datePublishedReg": "2009-01-01", 
    "description": "Prognosis of patients with initially unresectable metastatic colorectal cancer (MCRC) can be improved if chemotherapy induces a significant down-sizing of metastatic disease thus allowing a radical (R0) surgical resection of metastases (mts). Moreover, it has been demonstrated that there is a clear correlation between the activity of the regimen used and the rate of secondary R0 resections. We studied the triple drug combination FOLFOXIRI (irinotecan 165 mg/m2 on day 1, oxaliplatin 85 mg/m2 on day 1, 1-leucovorin 200 mg/m2 on day 1, 5-fluorouracil 3,200 mg/m2 48-h flat continuous infusion starting on day 1, repeated every 2 weeks) in phase II and III trials. Overall 196 patients with initially unresectable MCRC not selected for a neoadjuvant strategy were treated. This regimen was associated with a good activity (response rate ranging from 60 to 72%) and 37 patients (19%) underwent to a secondary R0 surgery on metastases after chemotherapy. Characteristics of the 37 radically resected patients were: median age 64 years (45-73), ECOG PS \u2265 1 in 11 patients (30%), median CEA 10 ng/ml (1\u2013288), liver involvement \u226525% in 18 patients (49%). Sites of disease were: liver only 25 patients (68%), lung only 4 patients (11%), liver + lymphnodes 5 patients (13%), liver + peritoneum 1 patient (3%), liver + lung 2 patients (5%). Mts were synchronous in 24 patients (65%) and metachronous in 13 patients (35%). There was no perioperative mortality. After a median follow up of 61 months, median OS is 40.8 months. The actuarial 5-year survival from the onset of chemotherapy is 45%. In 11 patients who showed progression of disease after surgery, a surgical re-resection and/or radiofrequency ablation was performed. These data indicate that FOLFOXIRI allows an R0 surgical resection in about 1 out of 5 patients with initially unresectable MCRC not selected for a neoadjuvant approach. Long term survival of resected patients is significant and comparable with the survival of patients resectable up-front. This FOLFOXIRI regimen should be considered as neoadjuvant treatment in initially unresectable metastatic colorectal cancer patients.", 
    "editor": [
      {
        "familyName": "Bonetti", 
        "givenName": "Andrea", 
        "type": "Person"
      }, 
      {
        "familyName": "Leone", 
        "givenName": "Roberto", 
        "type": "Person"
      }, 
      {
        "familyName": "Muggia", 
        "givenName": "Franco M.", 
        "type": "Person"
      }, 
      {
        "familyName": "Howell", 
        "givenName": "Stephen B.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-60327-459-3_32", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-60327-458-6", 
        "978-1-60327-459-3"
      ], 
      "name": "Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy", 
      "type": "Book"
    }, 
    "name": "First-Line Systemic Chemotherapy with Folfoxiri Followed by Radical Surgical Resection of Metastases for the Treatment of Unresectable Metastatic Colorectal Cancer Patients", 
    "pagination": "285-293", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-60327-459-3_32"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e4aaea7fe17674e9763d86a18d447199fe2924012988e67027a17cfd819b278c"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048001080"
        ]
      }
    ], 
    "publisher": {
      "location": "Totowa, NJ", 
      "name": "Humana Press", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-60327-459-3_32", 
      "https://app.dimensions.ai/details/publication/pub.1048001080"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T06:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000351_0000000351/records_43229_00000001.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-1-60327-459-3_32"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-459-3_32'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-459-3_32'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-459-3_32'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-459-3_32'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      23 PREDICATES      59 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-60327-459-3_32 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N4ca257c6b90b4f53a041c43759174eb5
4 schema:citation sg:pub.10.1007/bf00316981
5 sg:pub.10.1007/bf01655817
6 sg:pub.10.1007/s001040051278
7 sg:pub.10.1007/s10434-001-0347-3
8 sg:pub.10.1038/sj.bjc.6603233
9 sg:pub.10.1038/sj.bjc.6603988
10 sg:pub.10.1054/bjoc.1999.1254
11 sg:pub.10.1245/aso.2004.03.085
12 https://app.dimensions.ai/details/publication/pub.1079658535
13 https://doi.org/10.1002/bjs.1800840719
14 https://doi.org/10.1016/j.ejca.2006.04.012
15 https://doi.org/10.1016/j.jamcollsurg.2005.11.008
16 https://doi.org/10.1016/s0140-6736(00)02034-1
17 https://doi.org/10.1016/s0140-6736(94)92529-1
18 https://doi.org/10.1023/a:1008347829017
19 https://doi.org/10.1056/nejm200009283431302
20 https://doi.org/10.1093/annonc/mdg731
21 https://doi.org/10.1093/annonc/mdh217
22 https://doi.org/10.1093/annonc/mdh470
23 https://doi.org/10.1093/annonc/mdi246
24 https://doi.org/10.1097/00000658-199610000-00009
25 https://doi.org/10.1200/jco.1997.15.3.938
26 https://doi.org/10.1200/jco.2000.18.1.136
27 https://doi.org/10.1200/jco.2000.18.16.2938
28 https://doi.org/10.1200/jco.2002.12.075
29 https://doi.org/10.1200/jco.2004.05.113
30 https://doi.org/10.1200/jco.2004.11.037
31 https://doi.org/10.1200/jco.2005.00.349
32 https://doi.org/10.1200/jco.2005.05.546
33 https://doi.org/10.1200/jco.2006.09.0928
34 https://doi.org/10.1634/theoncologist.12-7-825
35 https://doi.org/10.3322/ca.2007.0010
36 schema:datePublished 2009
37 schema:datePublishedReg 2009-01-01
38 schema:description Prognosis of patients with initially unresectable metastatic colorectal cancer (MCRC) can be improved if chemotherapy induces a significant down-sizing of metastatic disease thus allowing a radical (R0) surgical resection of metastases (mts). Moreover, it has been demonstrated that there is a clear correlation between the activity of the regimen used and the rate of secondary R0 resections. We studied the triple drug combination FOLFOXIRI (irinotecan 165 mg/m2 on day 1, oxaliplatin 85 mg/m2 on day 1, 1-leucovorin 200 mg/m2 on day 1, 5-fluorouracil 3,200 mg/m2 48-h flat continuous infusion starting on day 1, repeated every 2 weeks) in phase II and III trials. Overall 196 patients with initially unresectable MCRC not selected for a neoadjuvant strategy were treated. This regimen was associated with a good activity (response rate ranging from 60 to 72%) and 37 patients (19%) underwent to a secondary R0 surgery on metastases after chemotherapy. Characteristics of the 37 radically resected patients were: median age 64 years (45-73), ECOG PS ≥ 1 in 11 patients (30%), median CEA 10 ng/ml (1–288), liver involvement ≥25% in 18 patients (49%). Sites of disease were: liver only 25 patients (68%), lung only 4 patients (11%), liver + lymphnodes 5 patients (13%), liver + peritoneum 1 patient (3%), liver + lung 2 patients (5%). Mts were synchronous in 24 patients (65%) and metachronous in 13 patients (35%). There was no perioperative mortality. After a median follow up of 61 months, median OS is 40.8 months. The actuarial 5-year survival from the onset of chemotherapy is 45%. In 11 patients who showed progression of disease after surgery, a surgical re-resection and/or radiofrequency ablation was performed. These data indicate that FOLFOXIRI allows an R0 surgical resection in about 1 out of 5 patients with initially unresectable MCRC not selected for a neoadjuvant approach. Long term survival of resected patients is significant and comparable with the survival of patients resectable up-front. This FOLFOXIRI regimen should be considered as neoadjuvant treatment in initially unresectable metastatic colorectal cancer patients.
39 schema:editor Nd91cf4b670724c0d8794debf98758b76
40 schema:genre chapter
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf Ned397e29ab2c4811859b7b09738541af
44 schema:name First-Line Systemic Chemotherapy with Folfoxiri Followed by Radical Surgical Resection of Metastases for the Treatment of Unresectable Metastatic Colorectal Cancer Patients
45 schema:pagination 285-293
46 schema:productId N0bda2ee87e504b1691670e41868197b5
47 N28711380621a4302b89b9c1f99df0dd4
48 Nec0ca0690b134b98b3d0d10b85e3e7c2
49 schema:publisher N53d6bb3dda454455a0b2d1b29a26da58
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048001080
51 https://doi.org/10.1007/978-1-60327-459-3_32
52 schema:sdDatePublished 2019-04-16T06:13
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher N43d427a1a0094a9184b964a70489ab7b
55 schema:url https://link.springer.com/10.1007%2F978-1-60327-459-3_32
56 sgo:license sg:explorer/license/
57 sgo:sdDataset chapters
58 rdf:type schema:Chapter
59 N074ecddc46ad4868a21232a9dd535fe1 rdf:first sg:person.01164506727.84
60 rdf:rest N393a66b568de41159834d8c2793055b9
61 N0bda2ee87e504b1691670e41868197b5 schema:name doi
62 schema:value 10.1007/978-1-60327-459-3_32
63 rdf:type schema:PropertyValue
64 N0e33880f57fd4d03aa72838ad0175b09 schema:familyName Muggia
65 schema:givenName Franco M.
66 rdf:type schema:Person
67 N2736e52cca89497b9b2bf0947a999182 schema:name Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
68 rdf:type schema:Organization
69 N28711380621a4302b89b9c1f99df0dd4 schema:name readcube_id
70 schema:value e4aaea7fe17674e9763d86a18d447199fe2924012988e67027a17cfd819b278c
71 rdf:type schema:PropertyValue
72 N393a66b568de41159834d8c2793055b9 rdf:first sg:person.01276011262.01
73 rdf:rest N9ac279a39cf2443193c2f7fb11d97fe3
74 N3d9de04addc0438db4c8fcf358500ed2 schema:name Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
75 rdf:type schema:Organization
76 N43d427a1a0094a9184b964a70489ab7b schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 N4aa1e93a507e436cbb1348892b34836f schema:name Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
79 rdf:type schema:Organization
80 N4ca257c6b90b4f53a041c43759174eb5 rdf:first sg:person.01006607213.66
81 rdf:rest Ne7581e40aac54144a4dd297dc04652c6
82 N53d6bb3dda454455a0b2d1b29a26da58 schema:location Totowa, NJ
83 schema:name Humana Press
84 rdf:type schema:Organisation
85 N6d2f3d4d7a284364b7f4bb37d38df882 schema:familyName Howell
86 schema:givenName Stephen B.
87 rdf:type schema:Person
88 N7a7012f59d1a4b96a1b71c14ea1af56e rdf:first N0e33880f57fd4d03aa72838ad0175b09
89 rdf:rest N9a17e50b85744a4fbd424478ed2fab62
90 N953c4858757f411f867428c0b54a9a85 rdf:first sg:person.01006230145.44
91 rdf:rest rdf:nil
92 N983a6b829e6947f2b4db4fea194ba677 schema:name Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
93 rdf:type schema:Organization
94 N9a17e50b85744a4fbd424478ed2fab62 rdf:first N6d2f3d4d7a284364b7f4bb37d38df882
95 rdf:rest rdf:nil
96 N9ac279a39cf2443193c2f7fb11d97fe3 rdf:first sg:person.01157052153.90
97 rdf:rest N953c4858757f411f867428c0b54a9a85
98 Nb326da5e43764e25ba7ea17aa34c263c schema:name Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
99 rdf:type schema:Organization
100 Nb6f5fc0bbb0c4aaeb1cbe2e86fc8e241 schema:familyName Leone
101 schema:givenName Roberto
102 rdf:type schema:Person
103 Nb926801adb0a43059b0e0da15ffec485 rdf:first Nb6f5fc0bbb0c4aaeb1cbe2e86fc8e241
104 rdf:rest N7a7012f59d1a4b96a1b71c14ea1af56e
105 Nbbe3e3e4554e4e0d9e7212a29662685d schema:familyName Bonetti
106 schema:givenName Andrea
107 rdf:type schema:Person
108 Nc557e817cd3c486fa809619cbd515b7f schema:name Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
109 rdf:type schema:Organization
110 Nd2d4456c4aa7460dab3e04bb2ff1764b rdf:first sg:person.0602037071.94
111 rdf:rest Nf4212d8aaf0e4cf6a69ab092768e338e
112 Nd91cf4b670724c0d8794debf98758b76 rdf:first Nbbe3e3e4554e4e0d9e7212a29662685d
113 rdf:rest Nb926801adb0a43059b0e0da15ffec485
114 Nde74301c5e2e46fa84189b911f447cea schema:name Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
115 rdf:type schema:Organization
116 Ne20d6447e1fd424ea00e00d939e6f8ba rdf:first sg:person.01175106504.32
117 rdf:rest Nd2d4456c4aa7460dab3e04bb2ff1764b
118 Ne7581e40aac54144a4dd297dc04652c6 rdf:first sg:person.01062670207.83
119 rdf:rest Ne20d6447e1fd424ea00e00d939e6f8ba
120 Nec0ca0690b134b98b3d0d10b85e3e7c2 schema:name dimensions_id
121 schema:value pub.1048001080
122 rdf:type schema:PropertyValue
123 Ned397e29ab2c4811859b7b09738541af schema:isbn 978-1-60327-458-6
124 978-1-60327-459-3
125 schema:name Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy
126 rdf:type schema:Book
127 Nf4212d8aaf0e4cf6a69ab092768e338e rdf:first sg:person.0712424371.11
128 rdf:rest N074ecddc46ad4868a21232a9dd535fe1
129 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical and Health Sciences
131 rdf:type schema:DefinedTerm
132 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
133 schema:name Oncology and Carcinogenesis
134 rdf:type schema:DefinedTerm
135 sg:person.01006230145.44 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
136 schema:familyName Falcone
137 schema:givenName Alfredo
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006230145.44
139 rdf:type schema:Person
140 sg:person.01006607213.66 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
141 schema:familyName Vasile
142 schema:givenName Enrico
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006607213.66
144 rdf:type schema:Person
145 sg:person.01062670207.83 schema:affiliation Nc557e817cd3c486fa809619cbd515b7f
146 schema:familyName Masi
147 schema:givenName Gianluca
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062670207.83
149 rdf:type schema:Person
150 sg:person.01157052153.90 schema:affiliation Nb326da5e43764e25ba7ea17aa34c263c
151 schema:familyName Salvatore
152 schema:givenName Lisa
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157052153.90
154 rdf:type schema:Person
155 sg:person.01164506727.84 schema:affiliation N3d9de04addc0438db4c8fcf358500ed2
156 schema:familyName Fornaro
157 schema:givenName Lorenzo
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164506727.84
159 rdf:type schema:Person
160 sg:person.01175106504.32 schema:affiliation N2736e52cca89497b9b2bf0947a999182
161 schema:familyName Loupakis
162 schema:givenName Fotios
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175106504.32
164 rdf:type schema:Person
165 sg:person.01276011262.01 schema:affiliation Nde74301c5e2e46fa84189b911f447cea
166 schema:familyName Stasi
167 schema:givenName Irene
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276011262.01
169 rdf:type schema:Person
170 sg:person.0602037071.94 schema:affiliation N983a6b829e6947f2b4db4fea194ba677
171 schema:familyName Cupini
172 schema:givenName Samanta
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602037071.94
174 rdf:type schema:Person
175 sg:person.0712424371.11 schema:affiliation N4aa1e93a507e436cbb1348892b34836f
176 schema:familyName Baldi
177 schema:givenName Giacomo Giulio
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712424371.11
179 rdf:type schema:Person
180 sg:pub.10.1007/bf00316981 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038122014
181 https://doi.org/10.1007/bf00316981
182 rdf:type schema:CreativeWork
183 sg:pub.10.1007/bf01655817 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038580705
184 https://doi.org/10.1007/bf01655817
185 rdf:type schema:CreativeWork
186 sg:pub.10.1007/s001040051278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014305349
187 https://doi.org/10.1007/s001040051278
188 rdf:type schema:CreativeWork
189 sg:pub.10.1007/s10434-001-0347-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015538540
190 https://doi.org/10.1007/s10434-001-0347-3
191 rdf:type schema:CreativeWork
192 sg:pub.10.1038/sj.bjc.6603233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042776899
193 https://doi.org/10.1038/sj.bjc.6603233
194 rdf:type schema:CreativeWork
195 sg:pub.10.1038/sj.bjc.6603988 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000295738
196 https://doi.org/10.1038/sj.bjc.6603988
197 rdf:type schema:CreativeWork
198 sg:pub.10.1054/bjoc.1999.1254 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044768203
199 https://doi.org/10.1054/bjoc.1999.1254
200 rdf:type schema:CreativeWork
201 sg:pub.10.1245/aso.2004.03.085 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046932661
202 https://doi.org/10.1245/aso.2004.03.085
203 rdf:type schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1079658535 schema:CreativeWork
205 https://doi.org/10.1002/bjs.1800840719 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049625308
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/j.ejca.2006.04.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029538220
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/j.jamcollsurg.2005.11.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051692921
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/s0140-6736(00)02034-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006410174
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/s0140-6736(94)92529-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051430862
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1023/a:1008347829017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303343
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1056/nejm200009283431302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010303757
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1093/annonc/mdg731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051607149
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1093/annonc/mdh217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024390903
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1093/annonc/mdh470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017702605
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1093/annonc/mdi246 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028947330
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1097/00000658-199610000-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060134371
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1200/jco.1997.15.3.938 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083057206
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1200/jco.2000.18.1.136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074572224
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1200/jco.2000.18.16.2938 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074684744
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1200/jco.2002.12.075 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203208
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1200/jco.2004.05.113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025767346
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1200/jco.2004.11.037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034270716
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1200/jco.2005.00.349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204185
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1200/jco.2005.05.546 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001923432
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1200/jco.2006.09.0928 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029306962
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1634/theoncologist.12-7-825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037813481
248 rdf:type schema:CreativeWork
249 https://doi.org/10.3322/ca.2007.0010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052065817
250 rdf:type schema:CreativeWork
251 https://www.grid.ac/institutes/grid.5395.a schema:alternateName University of Pisa
252 schema:name Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Italy
253 Division of Medical Oncology, Azienda USL 6, Istituto Toscano Tumori, Livorno, Italy
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...